The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

When it comes to managing type 2 diabetes and supporting weight loss, patients often face the choice between Semaglutide ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Novo Nordisk, maker of Ozempic and Wegovy, now has a market capitalization of more than ... paying patients who are willing ...

The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence ...

Investors have sent stocks and bonds higher on expectations of a soft landing. But some Republicans think the central bank ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...